Skip to main content

Holocene Advisors, LP

Position in GILD — Gilead Sciences, Inc.

CIK 1700574 New York, NY

Position in GILD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$364,010,189
-$147,132,931 QoQ
Shares Held
2,611,826
-37.3% QoQ
Ownership
0.210%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Jun 30, 2025
CallValue
$133,044,000
CallShares
1,200,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

Holocene Advisors, LP holds $1,499,965,087 across 7 Drug Manufacturers - General names. GILD ranks #2 (24.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 GILD
Gilead Sciences, Inc.
This page
2,611,826 $364,010,189

All Filings in GILD

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $364,010,189 2,611,826
2025-12-31 $511,143,120 4,164,438
2025-09-30 $290,506,092 2,617,172
2025-06-30 $468,644,274 4,226,971
2025-06-30 $133,044,000 1,200,000
2025-03-31 $258,596,945 2,307,871
2022-03-31 $1,528,637 25,713
2021-03-31 $93,067,200 1,440,000
2021-03-31 $131,732,873 2,038,262
2020-12-31 $55,929,600 960,000
2020-12-31 $71,448,024 1,226,365
2020-06-30 $49,372,398 641,700